Here’s what you should know:
1. Five analyst firms made predictions on Valeant’s quarterly sales, the lowest estimate was $2.09 billion, while the highest was $2.24 billion.
2. If the estimates are correct, it shows Valeant sales decreased 9.6 percent year over year.
3. Valeant will announce its quarterly earnings Feb. 27.
4. Analysts anticipate full-year sales between $8.65 billion to $8.80 billion.
More articles on supply chain:
Campbell Clinic receives 8-year tax abatement for $30M expansion with ASC — 4 insights
Maximize your 2018 reimbursements: Know your health plans, know your market, and stay on top of trends
21 statistics on ASC accounts receivable
